期刊文献+

蒽环类抗肿瘤药物对心脏毒性防治的研究进展 被引量:11

原文传递
导出
摘要 20世纪70年代初,蒽环类药物以阿霉素(doxorubicin,ADM)为代表开始应用于临床,随后20年有许多蒽环类药物问世,如柔红霉素、阿柔比星、表阿霉素(表柔比星)、伊达比星、米托蒽醌等。在结构方面,它们都具有一个脱氧糖和一个四元芳香稠环;在药物作用机制方面:蒽环类药物进入癌细胞后,破坏癌细胞DNA结构,使DNA链裂解,通过抑制癌细胞DNA和RNA的合成来达到抗肿瘤作用。
出处 《华南国防医学杂志》 CAS 2015年第1期80-82,共3页 Military Medical Journal of South China
  • 相关文献

参考文献9

  • 1Erdoan D,Yücel H,Alanolu EG,et al.Can comprehensive echo-cardiographic evaluation provide an advantage to predict anthracy-cline-induced cardiomyopathy. Turk Kardiyol Dern Ars . 2011
  • 2G Minotti,P Menna,E Salvatorelli,G Cairo,L Gianni.Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacological Research . 2004
  • 3Medvedev P V,Nikitin E A,Pivnik A V.[The therapeutic efficacy and toxicity of the liposomal form of daunorubicin (Daunoxome) in lymphosarcoma patients]. Terapevticheski? arkhiv . 2000
  • 4Barry Elly,Alvarez Jorge A,Scully Rebecca E,Miller Tracie L,Lipshultz Steven E.Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert opinion on pharmacotherapy . 2007
  • 5Rafiyath Shamudheen M,Rasul Mohammad,Lee Byung,Wei Guoqing,Lamba Gurpreet,Liu Delong.Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis. Experimental hematology & oncology . 2012
  • 6James H. Doroshow.Dexrazoxane for the Prevention of Cardiac Toxicity and Treatment of Extravasation Injury from the Anthracycline Antibiotics. Current Pharmaceutical Biotechnology . 2012
  • 7Agnes F. Semsei,Daniel J. Erdelyi,Ildiko Ungvari.ABCC1 polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia. Cell Biology International . 2012
  • 8Horacek JM,Jebavy L,Vasatova M,et al.Glycogen phosphorylase BB as a potential marker of cardiac toxicity in patients treated with anthracyclines for acute leukemia. Bratislavske Lekarske Listy . 2013
  • 9Kotwinski P,Smith G,Sanders J,et al.The breast cancer,early disease:toxicity from therapy with epirubicin regimens-cardiac assessment and risk evaluation (BETTER-CARE)study:CMR with early gadolinium relative enhancement,but not high-sensitivity troponin T,predicts the risk of chronic anthra. Journal of Cardiovascular Magnetic Resonance . 2013

同被引文献124

引证文献11

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部